Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

More articles from Cystic fibrosis

  • Lung Clearance Index (LCI) derived from N2-Multiple Breath Washout (MBW) depicts worsening in airways colonization in pediatric Cystic Fibrosis (CF) patients (pts)
    Francesca Lucca, Sonia Volpi, Antonella Borruso, Laura Menin, Emily Pintani, Marco Cipolli
    European Respiratory Journal Sep 2020, 56 (suppl 64) 354; DOI: 10.1183/13993003.congress-2020.354
  • Sleep duration and activity of exacerbated and non-exacerbated cystic fibrosis patients during their hospital stay
    Carolin-Maria Linker, Svenja Straßburg, Sarah Dietz-Terjung, Matthias Welsner, Sebastian Brato, Christian Taube, Christoph Schöbel, Jürgen Götze, Gerhard Weinreich
    European Respiratory Journal Sep 2020, 56 (suppl 64) 360; DOI: 10.1183/13993003.congress-2020.360
  • European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN): structure and impact since 2009
    Silke Van Koningsbruggen-Rietschel, Damian G. Downey, Lieven Dupont, Fiona Dunlevy, Veerle Bulteel, Kate Hayes, Nick Simmonds, Nadine Dufeu, Hettie M. Janssens, Dorota Sands, Paola De Carli, Isabelle Sermet-Gaudelus, Kris De Boeck, Tim Lee, Isabelle Fajac
    European Respiratory Journal Sep 2020, 56 (suppl 64) 367; DOI: 10.1183/13993003.congress-2020.367
  • Rescue of CFTR function impaired by mutations in exon 15
    Kelly Martinovich, Anthony Kicic, Sue Fletcher, Steve Wilton, Steve Stick
    European Respiratory Journal Sep 2020, 56 (suppl 64) 361; DOI: 10.1183/13993003.congress-2020.361
  • Vitamin D status correlates with lung function in children and adolescents with cystic fibrosis
    Elena Zhekaite, Elena Kondratyeva, Anna Voronkova, Viktoria Sherman, Roman Budzinsky, Aisa Zodbinova, Yulia Melyanovskaya
    European Respiratory Journal Sep 2020, 56 (suppl 64) 366; DOI: 10.1183/13993003.congress-2020.366
  • Blood gas analysis to predict survival in patients with cystic fibrosis
    Johanna Manuela Kurz, Ben Spycher, Romy Rodriguez, Reta Fischer Biner, Philipp Latzin, Florian Singer
    European Respiratory Journal Sep 2020, 56 (suppl 64) 358; DOI: 10.1183/13993003.congress-2020.358
  • Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis?
    Elpis Hatziagorou, Katerina Manika, S.S. Kyrvasili, E Kouroukli, E Sourla, I Lialias, S.C. Kotoulas, M Sionidou, J Kioumis, J Tsanakas
    European Respiratory Journal Sep 2020, 56 (suppl 64) 368; DOI: 10.1183/13993003.congress-2020.368
  • Shedding light into the black box of infant multiple-breath washout
    Marc-Alexander Oestreich, Florian Wyler, Philipp Latzin, Kathryn Ramsey
    European Respiratory Journal Sep 2020, 56 (suppl 64) 355; DOI: 10.1183/13993003.congress-2020.355
  • Electrical impedance tomography as a clinical monitoring tool in patients with cystic fibrosis
    Anna Folino, Sheila Beux, Laura Barrocu, Irene Esposito, Benedetta Crida, Roberta Cotti, Lorenzo Appendini, Elisabetta Bignamini
    European Respiratory Journal Sep 2020, 56 (suppl 64) 352; DOI: 10.1183/13993003.congress-2020.352
  • Electronic nose (E-nose) analysis of exhaled volatile organic compounds (VOCs) distinguishes pediatric patients (pts) with Cystic fibrosis (CF) from healthy controls (HC) and depicts disease status
    Francesca Lucca, Sonia Volpi, Laura Tenero, Michele Piazza, Marco Sandri, Marco Cipolli, Giorgio Piacentini
    European Respiratory Journal Sep 2020, 56 (suppl 64) 353; DOI: 10.1183/13993003.congress-2020.353

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 33

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society